Risk factors for death from COVID-19
| Variable | Unadjusted OR (95% CI) | P value |
| Cancer on treatment | 12.63 (3.5 to 42.3) | <0.001 |
| Chronic kidney disease | 10.65 (6.21 to 18.28) | <0.001 |
| Cancer previous | 8.16 (0.51 to 131.14) | 0.138 |
| Cardiac failure | 5.63 (3.21 to 9.87) | <0.001 |
| Post-TB SLD | 4.14 (1.23 to 13.9) | 0.022 |
| Hypertension | 3.95 (2.73 to 5.70) | <0.001 |
| Type 2 diabetes | 3.1 (2.2 to 4.3) | <0.001 |
| TB on treatment | 2.94 (1.14 to 7.57) | 0.026 |
| Ischaemic heart disease | 2.06 (0.76 to 5.58) | 0.154 |
| Hypercholesterolaemia | 1.88 (1.04 to 3.37) | 0.035 |
| TB previous | 1.88 (0.89 to 3.95) | 0.097 |
| Overweight/Obese | 1.69 (1.15 to 2.49) | 0.007 |
| HIV | 1.67 (1.09 to 2.56) | 0.019 |
| Male sex | 1.63 (1.16 to 2.30) | 0.005 |
| COPD | 1.34 (0.59 to 3.03) | 0.487 |
| Asthma | 1.11 (0.52 to 2.36) | 0.795 |
| Type 1 diabetes | 1.08 (0.24 to 4.78) | 0.916 |
| Increasing age | 1.06 (1.05 to 1.07) | <0.001 |
| Turnaround time | 1.02 (0.99 to 1.06) | 0.216 |
| Tobacco smoking | 1.01 (0.46 to 2.21) | 0.986 |
| Length of admission | 0.97 (0.93 to 1.02) | 0.219 |
| Rural versus metro services | 0.77 (0.51 to 1.16) | 0.208 |
| No comorbidities | 0.17 (0.09 to 0.30) | <0.001 |
| Variable | Adjusted OR (95% CI) | P value |
| Cancer on treatment | 7.45 (1.87 to 29.89) | 0.004 |
| Chronic kidney disease | 5.16 (2.82 to 9.43) | <0.001 |
| HIV | 3.41 (2.06 to 5.65) | <0.001 |
| Cardiac failure | 2.85 (1.52 to 5.35) | 0.001 |
| Male sex | 2.02 (1.37 to 2.98) | <0.001 |
| Type 2 diabetes | 1.84 (1.24 to 2.73) | 0.002 |
| Overweight/Obese | 1.58 (1.02 to 2.46) | 0.04 |
| Increasing age | 1.06 (1.04 to 1.07) | <0.001 |
COPD, chronic obstructive pulmonary disease; SLD, structural lung damage; TB, tuberculosis.